Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants

N Engl J Med. 2023 Jun 29;388(26):2490. doi: 10.1056/NEJMc2304780.

Authors

Maria Jose Soler¹, Richard J Glassock², Fernando C Fervenza³

Affiliations

¹ Hospital Universitari Vall d'Hebron, Barcelona, Spain.
² Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA.
³ Mayo Clinic College of Medicine and Science, Rochester, MN fervenza.fernando@mayo.edu.

PMID: 37379147
DOI: 10.1056/NEJMc2304780

No abstract available

Publication types

Letter
Comment

MeSH terms

Apolipoprotein L1 / genetics
Humans
Kidney Diseases* / genetics
Kidney Failure, Chronic*

Substances

Apolipoprotein L1
APOL1 protein, human